Brief: Samsung Biologics Selects Rapid Micro Biosystems' Growth Direct Platform To Automate Critical Microbiology Quality Control Testing
04/01/2024 12:18
Jan 4 (Reuters) - Rapid Micro Biosystems:
* SAMSUNG BIOLOGICS CO LTD: SELECTS RAPID MICRO BIOSYSTEMS'
GROWTH
DIRECT PLATFORM TO AUTOMATE CRITICAL MICROBIOLOGY QUALITY
CONTROL TESTING
Source text for Eikon: ID:nGNX5Cl2GH
Further company coverage: 207940.KS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rapid Micro Biosystems
See all newsRapid Micro Biosystems, Inc. reports results for the quarter ended June 30 - Earnings Summary
Rapid Micro Biosystems Q2 revenue beats; reaffirms 2026 revenue forecast
Rapid Micro Biosystems, Inc. expected to post a loss of 24 cents a share - Earnings Preview
Brief: Rapid Micro Biosystems Announces Pricing Of Up To Around $32 Million Underwritten Offering
Rapid Micro Biosystems Q1 net loss widens, misses estimates